Literature DB >> 9847054

Developmental aspects of NMDA receptor function.

M L Vallano1.   

Abstract

Glutamate is the major excitatory neurotransmitter in mammalian synapses. It binds to three classes of predominantly postsynaptic ionotropic receptors to activate receptor-associated channels, and a class of metabotropic receptors to activate G-protein mediated transduction pathways. The N-methyl-D-aspartate (NMDA) receptor (NR) is distinctive in being both ligand and voltage-gated, and selectively permeable to Ca2+. As a consequence, NR-mediated alterations in intracellular Ca2+ levels regulate a variety of signaling pathways, ranging from localized, acute effects on receptor and channel activities to long-term effects on nuclear gene transcription. Regulated expression, assembly, and modulation of distinct heteromeric NR complexes comprised of different subunit combinations contributes to this functional diversity. NRs have been implicated in several developmental processes, and evidence supporting their role in migration, survival, and synaptic maturation is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9847054     DOI: 10.1615/critrevneurobiol.v12.i3.20

Source DB:  PubMed          Journal:  Crit Rev Neurobiol        ISSN: 0892-0915


  8 in total

1.  Three rare diseases in one Sib pair: RAI1, PCK1, GRIN2B mutations associated with Smith-Magenis Syndrome, cytosolic PEPCK deficiency and NMDA receptor glutamate insensitivity.

Authors:  David R Adams; Hongjie Yuan; Todd Holyoak; Katrina H Arajs; Parvin Hakimi; Thomas C Markello; Lynne A Wolfe; Thierry Vilboux; Barbara K Burton; Karin Fuentes Fajardo; George Grahame; Conisha Holloman; Murat Sincan; Ann C M Smith; Gordon A Wells; Yan Huang; Hugo Vega; James P Snyder; Gretchen A Golas; Cynthia J Tifft; Cornelius F Boerkoel; Richard W Hanson; Stephen F Traynelis; Douglas S Kerr; William A Gahl
Journal:  Mol Genet Metab       Date:  2014-04-13       Impact factor: 4.797

2.  Effect of the selective NMDA NR2B antagonist, ifenprodil, on acute tolerance to ethanol-induced motor impairment in adolescent and adult rats.

Authors:  Ruby Liane Ramirez; Elena I Varlinskaya; Linda P Spear
Journal:  Alcohol Clin Exp Res       Date:  2011-02-25       Impact factor: 3.455

3.  Neuroprotection associated with alternative splicing of NMDA receptors in rat cortical neurons.

Authors:  Beate Jaekel; Katja Mühlberg; Susana Garcia de Arriba; Andreas Reichenbach; Ester Verdaguer; Mercè Pallas; Antoni Camins; Wolfgang Nörenberg; Clemens Allgaier
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

4.  A hippocampal NR2B deficit can mimic age-related changes in long-term potentiation and spatial learning in the Fischer 344 rat.

Authors:  Daniel A Clayton; Michael H Mesches; Enriquez Alvarez; Paula C Bickford; Michael D Browning
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

5.  Glutamate receptor subunit expression in the rhesus macaque locus coeruleus.

Authors:  Nigel C Noriega; Vasilios T Garyfallou; Steven G Kohama; Henryk F Urbanski
Journal:  Brain Res       Date:  2007-08-09       Impact factor: 3.252

6.  Amyloid precursor protein 96-110 and beta-amyloid 1-42 elicit developmental anomalies in sea urchin embryos and larvae that are alleviated by neurotransmitter analogs for acetylcholine, serotonin and cannabinoids.

Authors:  Gennady A Buznikov; Lyudmila A Nikitina; Frederic J Seidler; Theodore A Slotkin; Vladimir V Bezuglov; Ivan Milosević; Lidija Lazarević; Ljubica Rogac; Sabera Ruzdijić; Ljubisa M Rakić
Journal:  Neurotoxicol Teratol       Date:  2008-05-16       Impact factor: 3.763

Review 7.  Glutamate antagonists are neurotoxins for the developing brain.

Authors:  Angela M Kaindl; Chrysanthy Ikonomidou
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

8.  Intrahippocampal administration of an NMDA-receptor antagonist impairs spatial discrimination reversal learning in weanling rats.

Authors:  Deborah J Watson; Mark E Stanton
Journal:  Neurobiol Learn Mem       Date:  2009-02-25       Impact factor: 2.877

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.